Shares of Stratagene gained 9.5 percent to lead all stocks in the BCW Index for the trading week ended Tuesday. The firm's shares have risen 27 percent since hitting a 52-week low on June 27. Stratagene was only one of four companies in the Index to gain ground for the tracking period. Invitrogen and Agilent led the decliners for the week, falling 5.6 percent and 5.3 percent, respectively.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.